Dr. Matthew J. Ellis on Neoadjuvant Palbociclib in Primary Breast Cancer

December 15, 2015
Matthew J. Ellis, MD, PhD

Special Reports, Breast Cancer (Issue 2), Volume 1, Issue 2

Matthew J. Ellis, MD, PhD, director, Sue Smith Breast Center at Baylor College of Medicine, discusses a recent study of palbociclib in primary breast cancer.

Matthew J. Ellis, MD, PhD, director, Sue Smith Breast Center at Baylor College of Medicine, discusses a recent study of palbociclib in primary breast cancer. Ellis says while all the data on palbociclib prior to this study was in metastatic disease, this study looked at the treatment in the neoadjuvant setting for patient with breast cancer.